![Alprostadil Vitaros 3mg Cream, Non Prescription, Treatment: Erectile Dysfunction, Rs 200 /packet | ID: 24489485530 Alprostadil Vitaros 3mg Cream, Non Prescription, Treatment: Erectile Dysfunction, Rs 200 /packet | ID: 24489485530](https://5.imimg.com/data5/SELLER/Default/2022/1/AJ/YE/NN/138692332/vitaros-3mg-cream-250x250.jpg)
Alprostadil Vitaros 3mg Cream, Non Prescription, Treatment: Erectile Dysfunction, Rs 200 /packet | ID: 24489485530
![The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over clinical trial | International Journal of Impotence Research The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over clinical trial | International Journal of Impotence Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41443-018-0087-6/MediaObjects/41443_2018_87_Fig1_HTML.png)
The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over clinical trial | International Journal of Impotence Research
![Woman injured after being prescribed erectile dysfunction cream for dry eye | London Evening Standard | Evening Standard Woman injured after being prescribed erectile dysfunction cream for dry eye | London Evening Standard | Evening Standard](https://static.standard.co.uk/s3fs-public/thumbnails/image/2019/01/08/14/creamscompositevitaros080119a.jpg?width=1200&width=1200&auto=webp&quality=75)
Woman injured after being prescribed erectile dysfunction cream for dry eye | London Evening Standard | Evening Standard
![Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study | International Journal of Impotence Research Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study | International Journal of Impotence Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41443-020-00400-9/MediaObjects/41443_2020_400_Fig1_HTML.png)